How New Jersey patients can access W8MD medical weight-loss care through nearby offices and telemedicine when appropriate

Patients often ask whether they should choose a traditional diet program, an online GLP-1 service, a primary care visit, or a dedicated medical weight-loss clinic. W8MD’s approach is to combine affordability with medical supervision, follow-up and local accountability.

Eligible patients may be evaluated for semaglutide, tirzepatide, Wegovy, Zepbound, Mounjaro-related care, Foundayo/orforglipron, phentermine, phentermine/topiramate, Contrave, orlistat, meal replacements, VLCD plans, sleep apnea testing and long-term maintenance support.

• Semaglutide from $29.99/week and up with insurance accepted for qualifying visits.
• Tirzepatide from $45/week and up with insurance accepted for qualifying visits.
• Self-pay semaglutide from $59.99/week and up.
• Self-pay tirzepatide from $69.99/week and up.
• Over 15 years of experience helping thousands of W8MD patients lose weight and maintain results.